Sinusoidal Obstruction Syndrome in Children with CD22+ B-Cell Precursors Acute Lymphoblastic Leukemia (BCP-ALL) Treated with Inotuzumab Ozogamicin in Trial ITCC-059: Risk Factors and Outcomes
Erica Brivio(Princess Máxima Center), C. Michel Zwaan(Hôpital Saint-Michel), Inge M. van der Sluis(Princess Máxima Center), Carine Halfon‐Domenech(Institut d’Hématologie et d’Oncologie Pédiatrique), Franco Locatelli(Bambino Gesù Children's Hospital), Susana Rives(Hospital Sant Joan de Déu Barcelona), Marlène Pasquet(Centre Hospitalier Universitaire de Toulouse), Gernot Engstler(St Anna Children's Hospital), Nicoletta Bertorello(Ospedale Regina Margherita), Anneke C. J. Ammerlaan(Princess Máxima Center), Arnaud Petit(Sorbonne Université), Uta Dirksen(Essen University Hospital), Caroline A. Lindemans(University Medical Center Utrecht), Andrej Lissat(Charité - Universitätsmedizin Berlin), Carmelo Rizzari(Hôpital Saint-Michel), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Edoardo Pennesi(Princess Máxima Center), Fanny Rialland Battisti(Hotel Dieu Hospital), Lucie Šrámková(University Hospital in Motol), Barbara De Moerloose(Ghent University Hospital), Bella Bielorai, Alba Rubio‐San‐Simón(Hospital del Niño), Karsten Nysom(Copenhagen University Hospital), Peter McCarthy(Children's Health Ireland at Crumlin), Bénedicte Bruno(Centre Hospitalier Universitaire de Lille), Benoît Brethon(Hôpital Saint-Louis), Jochen Büchner(Oslo University Hospital), Claudia Rössig(Klinik und Poliklinik für Kinder- und Jugendmedizin)
Cited by 5
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738